WHO ICTRP trial
Born early, breathe easy
ISRCTN14767962 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN14767962 |
|---|---|
| Public title | Born early, breathe easy |
| Scientific title | Respiratory Health Outcomes in Neonates - A randomised, double blind, double-dummy placebo-controlled trial of inhaled treatment to establish the mechanisms of prematurity-associated airway obstruction and inflammation |
| Primary sponsor | Cardiff University |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | United Kingdom;Wales |
| Conditions | Prematurity-associated respiratory disease Neonatal Diseases |
| Interventions | Random assignment to using one of the three following metered-dose inhalers 1. Fluticasone proprionate 2. Fluticasone proprionate/salmeterol xinafoate combination 3. Placebo |
| Registration date | Dec 2, 2016 |
| Target size | 200 |
| Secondary IDs | 2015-003712-20;2015-003712-20 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: